EchoGo Pro

Ultromics

Outcomes-based AI system that predicts coronary artery disease.
Product specifications Information source: Vendor
Last updated: July 27, 2020
General
Product name EchoGo Pro
Company Ultromics
Subspeciality Cardiac
Modality US
Disease targeted Coronary Artery Disease
Key-features risk prediction, automated segmentation
Suggested use During: interactive decision support (shows abnormalities/results only on demand), report suggestion
After: diagnosis verification
Data characteristics
Population All stress echo indications in adults
Input Stress Echo
Input format DICOM
Output PDF Report with key quantification and findings
Output format PDF
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 10 - 60 seconds
Certification
CE Certified, Class I
FDA No or not yet
Market presence
On market since 03-2020
Distribution channels
Countries present (clinical, non-research use) 2
Paying clinical customers (institutes) 1
Research/test users (institutes) 2
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of analyses
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance

  • Automated Coronary Artery Disease Prediction (read)

Other relevant papers